M5717 330 mg + PYRONARIDINE

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

M5717 330 mg + PYRONARIDINE
Treatment and conditionWhere it standsTrials
M5717 330 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1